Timber Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.87 | -100% | 0 | 0% |
| P/S |
|
32.7 | 4.08 | 701.92% |
|
|
| P/BV |
|
0.5195 | 9.39 | -94.47% |
|
|
| P/FCF |
|
-0.2642 | 46.57 | -100.57% |
|
|
| Ev/Ebitda |
|
0.3147 | 17.62 | -98.21% |
|
|
| Ev/S |
|
-72.29 | 4.37 | -1754.69% |
|
|
| Ev/FCF |
|
0.3774 | 54.59 | -99.31% |
|
|
| E/P |
|
-4.62 | 0.2164 | -2234.67% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-23032.75 | 20.15 | -114417.44% | -8377.03 | +174.95% |
| ROE |
|
-209.49 | -80.86 | 159.1% |
|
|
| ROA |
|
-137.55 | 6.71 | -2148.71% |
|
|
| ROIC |
|
0 | 15.68 | -100% |
|
|
| ROS |
|
-23373.49 | 10.56 | -221544.22% |
|
|
| ROCE |
|
-367.47 | 18.05 | -2135.73% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0172 | 2.87 | -100.6% | -0.0209 | -17.68% |
| Nеt Debt/Ebitda |
|
0.4531 | 3.69 | -87.73% |
|
|
| Debt/Ratio |
|
0.0321 | 0.2643 | -87.84% |
|
|
| Debt/Equity |
|
0.0338 | 4.49 | -99.25% |
|
|
| Debt/Net Income |
|
-0.0171 | 6.45 | -100.26% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.31 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 6.4 | -100% | ||
| DSI |
|
0 | 0.7399 | -100% |
|
|
| Average dividend growth |
|
0 | -2.86 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.3 | -100% |
|
|
| Average percentage for payments |
|
0 | 77.61 | -100% |
|
|
| Difference from average difference in sector |
|
-1.31 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-48.81 | 362.86 | -113.45% | ||
| Growth impulse Ebitda in 5 years |
|
95.65 | 373.75 | -74.41% | ||
| Growth impulse Net Income in 5 years |
|
100 | 353.29 | -71.69% | ||
| Growth impulse FCF in 5 years |
|
56.48 | 306.17 | -81.55% | ||
| Growth impulse EPS in 5 years |
|
2.15 | 354.79 | -99.39% |
IP Score
4.11/10
